Cited by 674Psychedelics and Drug StudiesPosttraumatic Stress Disorder ResearchElectroconvulsive Therapy Studies

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

Open access

Mithoefer, Michael C, Wagner, Mark T, Mithoefer, Ann T, Jerome, Lisa, Doblin, Rick·2011·Journal of Psychopharmacology

DOI 10.1177/0269881110378371PMC PMC3122379

Open this paper in CoChat — free account

Abstract

Case reports indicate that psychiatrists administered ±3,4-methylenedioxymethamphetamine (MDMA) as a catalyst to psychotherapy before recreational use of MDMA as 'Ecstasy' resulted in its criminalization in 1985. Over two decades later, this study is the first completed clinical trial evaluating MDMA as a therapeutic adjunct. Twenty patients with chronic posttraumatic stress disorder, refractory to both psychotherapy and psychopharmacology, were randomly assigned to psychotherapy with concomitant active drug (n = 12) or inactive placebo (n = 8) administered during two 8-h experimental psychotherapy sessions. Both groups received preparatory and follow-up non-drug psychotherapy. The primary outcome measure was the Clinician-Administered PTSD Scale, administered at baseline, 4 days after each experimental session, and 2 months after the second session. Neurocognitive testing, blood pressure, and temperature monitoring were performed. After 2-month follow-up, placebo subjects were offered the option to re-enroll in the experimental procedure with open-label MDMA. Decrease in Clinician-Administered PTSD Scale scores from baseline was significantly greater for the group that received MDMA than for the placebo group at all three time points after baseline. The rate of clinical response was 10/12 (83%) in the active treatment group versus 2/8 (25%) in the placebo group. There were no drug-related serious adverse events, adverse neurocognitive effects or clinically significant blood pressure increases. MDMA-assisted psychotherapy can be administered to posttraumatic stress disorder patients without evidence of harm, and it may be useful in patients refractory to other treatments.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1177/0269881110378371

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Emotional processing of fear: Exposure to corrective information.
Foa, E. B., & Kozak, M. J. (1986) · Psychological Bulletin · doi:10.1037/0033-2909.99.1.20 · Cited by 5,396
Combat Duty in Iraq and Afghanistan, Mental Health Problems, and Barriers to Care
Hoge, C. W., Castro, C. A., Messer, S. C., McGurk, D., Cotting, D. I., & Koffman, R. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040603 · Cited by 4,778
Oxytocin increases trust in humans
Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005) · Nature · doi:10.1038/nature03701 · Cited by 3,690
The Impact of Event Scale: Revised
Weiss, D. S. (2007) · Springer eBooks · doi:10.1007/978-0-387-70990-1_10 · Cited by 3,074
The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity
Randolph, C., Tierney, M. C., Mohr, E., & Chase, T. N. (1998) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/jcen.20.3.310.823 · Cited by 2,519
Paced Auditory Serial-Addition Task: A Measure of Recovery from Concussion
Gronwall, D. M. A. (1977) · Perceptual and Motor Skills · doi:10.2466/pms.1977.44.2.367 · Cited by 2,395
Clinician-administered PTSD scale: A review of the first ten years of research
Weathers, F. W., Keane, T. M., & Davidson, J. R. T. (2001) · Depression and Anxiety · doi:10.1002/da.1029 · Cited by 1,903
Invisible Wounds of War: Psychological and Cognitive Injuries, Their Consequences, and Services to Assist Recovery
Adamson, D. M., Burnam, M. A., Burns, R. M., Caldarone, L. B., Cox, R. A., D’Amico, E. J., Díaz, C., Eibner, C., Fisher, G., Helmus, T. C., et al. (2008) · RAND Corporation eBooks · doi:10.7249/mg720 · Cited by 1,713
Effective Treatments for PTSD
Freeman, A. M. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1112 · Cited by 1,667

Show all 67 references

Research works printed but not linked: 14

Breslau N, 2001, J Clin Psychiatry, 62, 16
Cloitre M, 2009, CNS Spectr, 14, 32
Committee on Treatment of Posttraumatic Stress Disorder, Institute of Medicine, 2008, Posttraumatic stress disorder: an assessment of the evidence
Derogatis LR, 1994, SCL-90-R: Administration, Scoring and Procedures Manual
First MB, 1997, Structured clinical interview for Axis II DSM-IV disorders: Patient Edition (SCID II)
First MB, 1994, Structured clinical interview for Axis I DSM -IV disorders: Patient Edition (SCID-I/P)
Grof S, 2000, Psychology of the Future
Ipser J, 2006, S Afr Med J, 96, 1088
Metzner R, 2001, Ecstasy: the complete guide, 182
Ogden PKM, 2006, Trauma and the body
Pahnke WN, 1971, Int J Clin Pharmacol, 4, 446
Stein DJ, 2009, CNS Spectr, 14, 25
10.1038/sj.npp.1395197 · DOI · Paper page
Wilbarger P, 1997, Sensory defensiveness and related social/emotional and neurological problems

Sorted by citations

Items 201–300 of 671

Translating Molecular and Neuroendocrine Findings in Posttraumatic Stress Disorder and Resilience to Novel Therapies
DePierro, J. M., Lepow, L., Feder, A., & Yehuda, R. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.07.009 · Cited by 41
A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders
Kisely, S. R., Connor, M. A., Somogyi, A. A., & Siskind, D. J. (2022) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674221083868 · Cited by 46
Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder
Zeifman, R. J., Kettner, H., Ross, S., Weiss, B., Mithoefer, M. C., Mithoefer, A. T., & Wagner, A. C. (2024) · European Journal of Psychotraumatology · doi:10.1080/20008066.2023.2297536 · Cited by 37
Self-Experimentations with Psychedelics Among Mental Health Professionals: LSD in the Former Czechoslovakia
Winkler, P., & Csémy, L. (2014) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2013.873158 · Cited by 39
Can MDMA Play a Role in the Treatment of Substance Abuse?
Jerome, L., Schuster, S., & Yazar‐Klosinski, B. (2013) · Current Drug Abuse Reviews · doi:10.2174/18744737112059990005 · Cited by 39
Psilocybin and MDMA reduce costly punishment in the Ultimatum Game
Gabay, A. S., Carhart-Harris, R. L., Mazibuko, N., Kempton, M. J., Morrison, P. D., Nutt, D., & Mehta, M. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-26656-2 · Cited by 41
Safety of psychological interventions for adult post-traumatic stress disorder: meta-analysis on the incidence and relative risk of deterioration, adverse events and serious adverse events
Hoppen, T. H., Lindemann, A. S., & Nexhmedin Morina, B. (2022) · The British Journal of Psychiatry · doi:10.1192/bjp.2022.111 · Cited by 41
Making a medicine out of MDMA
Sessa, B., & Nutt, D. (2015) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.152751 · Cited by 37
Clinical effectiveness of interventions for treatment-resistant anxiety in older people: a systematic review
Barton, S., Karner, C., Salih, F., Baldwin, D. S., & Edwards, S. J. (2014) · Health Technology Assessment · doi:10.3310/hta18500 · Cited by 36
The History of Psychedelics in Medicine
Sessa, B. (2016) · Springer eBooks · doi:10.1007/978-3-642-55214-4_96-1 · Cited by 44
Oxytocin receptor gene variations and socio-emotional effects of MDMA: A pooled analysis of controlled studies in healthy subjects
Vizeli, P., & Liechti, M. E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199384 · Cited by 37
Oxytocin and Behavior: Evidence for Effects in the Brain
Stevens, F. L., Wiesman, O., Feldman, R., Hurley, R. A., & Taber, K. H. (2013) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.13030061 · Cited by 38
Oxytocin receptor gene variation predicts subjective responses to MDMA
Bershad, A. K., Weafer, J. J., Kirkpatrick, M. G., Wardle, M. C., Miller, M. A., & de Wit, H. (2016) · Social Neuroscience · doi:10.1080/17470919.2016.1143026 · Cited by 35
Do adjuvant interventions improve treatment outcome in adult patients with posttraumatic stress disorder receiving trauma-focused psychotherapy? A systematic review
Michael, T., Schanz, C. G., Mattheus, H. K., Issler, T. C., Frommberger, U., Köllner, V., & Equit, M. (2019) · European Journal of Psychotraumatology · doi:10.1080/20008198.2019.1634938 · Cited by 35
Dosing Psychedelics and MDMA
Liechti, M. E., & Holze, F. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_270 · Cited by 37
MDMA and memory, addiction, and depression: dose-effect analysis
Pantoni, M. M., Kim, J. L., Alstyne, K. R. V., & Anagnostaras, S. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06086-9 · Cited by 41
Quality of reporting on psychological interventions in psychedelic treatments: a systematic review
Seybert, C., Schimmers, N., Silva, L., Breeksema, J. J., Veraart, J. K. E., Bessa, B. S., d’Orsi, D., Schoevers, R. A., & Oliveira-Maia, A. J. (2024) · The Lancet Psychiatry · doi:10.1016/s2215-0366(24)00333-x · Cited by 35
A Systematic Review of Participant Diversity in Psychedelic-Assisted Psychotherapy Trials
Haft, S. L., Downey, A. E., Raymond‐Flesch, M., Fernandes‐Osterhold, G., Bradley, E., O’Donovan, A., & Woolley, J. D. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2025.116359 · Cited by 38
Neuroscience Informed Prolonged Exposure Practice: Increasing Efficiency and Efficacy Through Mechanisms
Stojek, M. M., McSweeney, L. B., & Rauch, S. A. M. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00281 · Cited by 37
The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry
Kurtz, J. S., Patel, N., Gendreau, J. L., Yang, C., Brown, N. J., Bui, N., Picton, B., Harris, M., Hatter, M. J., Beyer, R. S., et al. (2022) · Cureus · doi:10.7759/cureus.29167 · Cited by 40
The Efficacy of MDMA (3,4-Methylenedioxymethamphetamine) for Post-traumatic Stress Disorder in Humans: A Systematic Review and Meta-Analysis
Tedesco, S., Gajaram, G., Chida, S., Ahmad, A., Pentak, M., Kelada, M., Lewis, L., Krishnan, D., Tran, C., Soetan, O. T., et al. (2021) · Cureus · doi:10.7759/cureus.15070 · Cited by 36
From non-pharmacological treatments for post-traumatic stress disorder to novel therapeutic targets
Hendriksen, H., Olivier, B., & Oosting, R. S. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.03.031 · Cited by 35
A Public-Health-Based Vision for the Management and Regulation of Psychedelics
Haden, M., Emerson, B., & Tupper, K. W. (2016) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2016.1202459 · Cited by 39
Prevalence and therapeutic impact of adverse life event reexperiencing under ceremonial ayahuasca
Weiss, B., Wingert, A., Erritzoe, D., & Campbell, W. K. (2023) · Scientific Reports · doi:10.1038/s41598-023-36184-3 · Cited by 33
Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research
McIntyre, R. S., Kwan, A. T. H., Mansur, R. B., Oliveira-Maia, A. J., Teopiz, K. M., Maletic, V., Suppes, T. M., Stahl, S. M., & Rosenblat, J. D. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230902 · Cited by 33
Nonlinear Pharmacokinetics of (±)3,4-Methylenedioxymethamphetamine (MDMA) and Its Pharmacodynamic Consequences in the Rat
Concheiro, M., Baumann, M. H., Scheidweiler, K. B., Rothman, R. B., Marrone, G. F., & Huestis, M. A. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.053678 · Cited by 32
Association between posttraumatic stress disorder and nonfatal drug overdose.
Lee, W. K., Hayashi, K., DeBeck, K., Milloy, M., Grant, C. C., Wood, E., & Kerr, T. H. (2019) · Psychological Trauma Theory Research Practice and Policy · doi:10.1037/tra0000511 · Cited by 33
Lifetime use of psychedelics is associated with better mental health indicators during the COVID-19 pandemic
Cavanna, F., Pallavicini, C., Milano, V., Cuiule, J. I., Tella, R. D., González, P., & Tagliazucchi, E. (2021) · Journal of Psychedelic Studies · doi:10.1556/2054.2021.00172 · Cited by 34
The renaissance in psychedelic research: What do preclinical models have to offer
Murnane, K. S. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.08.003 · Cited by 35
Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension
Jones, G. M., & Nock, M. K. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211058933 · Cited by 36
Pharmacological strategies for post-traumatic stress disorder (PTSD): From animal to clinical studies
Gasparyan, A., Navarro, D., Navarrete, F., & Manzanares, J. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109211 · Cited by 34
Social Cognition
Patin, A., & Hurlemann, R. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-16522-6_10 · Cited by 37
MDMA ‐assisted psychotherapy for the treatment of PTSD : A systematic review and meta‐analysis of randomized controlled trials ( RCTs )
Shahrour, G., Sohail, K., Elrais, S., Khan, M. H., Javeid, J., Samdani, K., Mansoor, H., Hussain, S. I., Sharma, D., Ehsan, M., et al. (2024) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12485 · Cited by 31
Effects of ecstasy on cooperative behaviour and perception of trustworthiness: A naturalistic study
Stewart, L. H., Ferguson, B., Morgan, C. J. A., Swaboda, N., Jones, L., Fenton, R., Wall, M. B., & Curran, H. V. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114544775 · Cited by 32
Stimulants, ecstasy, and other ‘party drugs’
WINSTOCK, A. R., & Flechais, R. (2020) · doi:10.1093/med/9780198713005.003.0053 · Cited by 29
The Role of Psychedelics and Counseling in Mental Health Treatment
Curtis, R., Roberts, L. C., Graves, E. G., Rainey, H. T., Wynn, D. D., Krantz, D., & Wieloch, V. (2020) · Journal of Mental Health Counseling · doi:10.17744/mehc.42.4.03 · Cited by 35
Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia—Relevance for Mental Diseases
Borroto‐Escuela, D. O., Ambrogini, P., Narváez, M., Liberto, V. D., Beggiato, S., Ferraro, L., Fores‐Pons, R., Alvarez‐Contino, J. E., López‐Salas, A., Mudò, G., et al. (2021) · Cells · doi:10.3390/cells10081902 · Cited by 29
Toward a New Science of Psychedelic Social Psychology: The Effects of MDMA (Ecstasy) on Social Connection
Lyubomirsky, S. (2022) · Perspectives on Psychological Science · doi:10.1177/17456916211055369 · Cited by 34
Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses
Wolfson, P. E., Andries, J., Ahlers, D., & Whippo, M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1141988 · Cited by 31
MDMA enhances hippocampal-dependent learning and memory under restrictive conditions, and modifies hippocampal spine density
Abad, S., Fole, A., Olmo, N. D., Pubill, D., Pallàs, M., Junyent, F., Camarasa, J., Camins, A., & Escubedo, E. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3304-5 · Cited by 29
Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models
Kyzar, E. J., & Kalueff, A. V. (2016) · Zebrafish · doi:10.1089/zeb.2016.1251 · Cited by 31
The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD
Brewerton, T. D., Lafrance, A., & Mithoefer, M. C. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110367 · Cited by 30
Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4h apart Human pharmacology of MDMA after repeated doses taken 4h apart
Farré, M., Tomillero, A., Pérez‐Mañá, C., Yubero‐Lahoz, S., Papaseit, E., Roset, P. N., Pujadas, M., Torrens, M., Camı́, J., & de la Torre, R. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.05.007 · Cited by 28
Ayahuasca as Antidepressant? Psychedelics and Styles of Reasoning in Psychiatry
Anderson, B. T. (2012) · Anthropology of Consciousness · doi:10.1111/j.1556-3537.2012.01056.x · Cited by 30
Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine
Fattore, L., Piva, A., Zanda, M. T., Fumagalli, G. F., & Chiamulera, C. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4793-4 · Cited by 26
Mental health of a self-selected sample of psychedelic users and self-medication practices with psychedelics
Mason, N. L., & Kuypers, K. P. C. (2018) · Journal of Psychedelic Studies · doi:10.1556/2054.2018.006 · Cited by 28
MDMA assisted psychotherapy found to have a large effect for chronic post-traumatic stress disorder
Chabrol, H. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113495119 · Cited by 28
Psychedelics as a Training Experience for Psychedelic Therapists: Drawing on History to Inform Current Practice
Nielson, E. M. (2021) · Journal of Humanistic Psychology · doi:10.1177/00221678211021204 · Cited by 29
Therapeutic frameworks in integration sessions in substance‐assisted psychotherapy: A systematised review
Thal, S. B., Baker, P., Marinis, J., Wieberneit, M., Sharbanee, J. M., Bruno, R., Skeffington, P., & Bright, S. J. (2023) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2945 · Cited by 32
A Gratuitous Grace: The Influence of Religious Set and Intent on the Psychedelic Experience
Neitzke‐Spruill, L., & Glasser, C. L. (2018) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2018.1494869 · Cited by 27
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
Ponomarenko, P., Seragnoli, F., Calder, A. E., Oehen, P., & Hasler, G. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231155117 · Cited by 31
Role of the gut–brain axis via the subdiaphragmatic vagus nerve in stress resilience of 3,4-methylenedioxymethamphetamine in mice exposed to chronic restrain stress
Qu, Y., Eguchi, A., Ma, L., Wan, X., Mori, C., & Hashimoto, K. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106348 · Cited by 27
Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis
Bahji, A., Lunsky, I. O., Gutiérrez, G., & Vázquez, G. H. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2278586 · Cited by 32
Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis
Hsu, T., Tsai, C., Kao, Y., Thompson, T., Carvalho, A. F., Yang, F., Tseng, P., Hsu, C.-W., Yu, C., Tu, Y., et al. (2024) · BMJ · doi:10.1136/bmj-2023-078607 · Cited by 28
Untitled work
(2024) · doi:10.1177/02698811231215420 · Cited by 25
Novel pharmacological treatment strategies for posttraumatic stress disorder
Thomas, E., & Stein, D. J. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1260001 · Cited by 24
Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose
Pantoni, M. M., & Anagnostaras, S. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017087 · Cited by 25
Cellular Uptake of Psychostimulants – Are High- and Low-Affinity Organic Cation Transporters Drug Traffickers?
Jensen, O., Rafehi, M., Gebauer, L., & Brockmöller, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.609811 · Cited by 26
Potential processes of change in MDMA‐Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self‐transcendence, and therapeutic relationships
Luoma, J. B., Shahar, B., Lear, M. K., Pilecki, B. C., & Wagner, A. (2021) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2824 · Cited by 29
Psychedelic innovations and the crisis of psychopharmacology
Langlitz, N. (2022) · BioSocieties · doi:10.1057/s41292-022-00294-4 · Cited by 24
Repeated use of 3,4-methylenedioxymethamphetamine is associated with the resilience in mice after chronic social defeat stress: A role of gut–microbiota–brain axis
Qu, Y., Eguchi, A., Wan, X., Ma, L., Chang, L., Shan, J., Yang, Y. H., Mori, C., & Hashimoto, K. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.115020 · Cited by 26
The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder
Amoroso, T. (2015) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2015.1094156 · Cited by 28
The conceptual framework for the therapeutic approach used in phase 3 trials of MDMA-assisted therapy for PTSD
O’Donnell, K. C., Alpert, M., Okano, L., Nicholas, C. R. N., Thomas, C., Poulter, B., Mithoefer, A. T., Mithoefer, M. C., & Marcela Ot’alora, G. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1427531 · Cited by 26
Therapeutic (Sub)stance: Current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy—A systematized review
Thal, S. B., Wieberneit, M., Sharbanee, J. M., Skeffington, P., Baker, P., Bruno, R., Wenge, T., & Bright, S. J. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221127954 · Cited by 24
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline
Feduccia, A. A., Jerome, L., Yazar‐Klosinski, B., Emerson, A., Mithoefer, M. C., & Doblin, R. (2023) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.23021013 · Cited by 24
Decision‐making in chronic ecstasy users: a systematic review
Betzler, F., Viohl, L., & Romanczuk‐Seiferth, N. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13480 · Cited by 26
Post-traumatic stress disorder: new directions in pharmacotherapy
Green, B. (2013) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.111.010041 · Cited by 25
Perceptions of the medicinal value of hallucinogenic drugs among college students
Wildberger, J., John, C. N., & Hallock, R. M. (2017) · Journal of Psychedelic Studies · doi:10.1556/2054.01.2017.008 · Cited by 23
Medication versus trauma-focused psychotherapy for adults with posttraumatic stress disorder: A systematic review and meta-analysis
Sonis, J. H., & Cook, J. M. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112637 · Cited by 26
Psychedelic drugs for psychiatric disorders
da Costa, S. C., Oesterle, T., Rummans, T. A., Richelson, E., & Gold, M. S. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120332 · Cited by 32
In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials
Soliman, P., Curley, D. E., Capone, C., Eaton, E. M., & Haass‐Koffler, C. L. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06598-6 · Cited by 28
Neurochemical binding profiles of novel indole and benzofuran MDMA analogues
Shimshoni, J. A., Winkler, I., Golan, E., & Nutt, D. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1297-4 · Cited by 23
Anxiolytic drug discovery: What are the novel approaches and how can we improve them?
Stewart, A. M., & Kalueff, A. V. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.857309 · Cited by 22
NADPH oxidase and redox status in amygdala, hippocampus and cortex of male Wistar rats in an animal model of post-traumatic stress disorder
Petrovic, R., Puškaš, L., Dožudić, G. J., Stojković, T., Velimirović, M., Nikolić, T., Živković, M., Djorovic, D. J., Nenadović, M., & Petronijević, N. (2018) · Stress · doi:10.1080/10253890.2018.1474874 · Cited by 22
Toward Risk-Benefit Assessments in Psychedelic- and MDMA-Assisted Therapies
Bradberry, M. M., Gukasyan, N., & Raison, C. L. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.0665 · Cited by 22
The illusion of knowledge in the emerging field of psychedelic research
Oña, G., Kohek, M., & Bouso, J. C. (2022) · New Ideas in Psychology · doi:10.1016/j.newideapsych.2022.100967 · Cited by 24
MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations
Kangaslampi, S., & Zijlmans, J. (2023) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-023-02310-9 · Cited by 27
Intersectional insights from an MDMA-assisted psychotherapy training trial: An open letter to racial/ethnic and sexual/gender minorities
Ching, T. H. W. (2019) · Journal of Psychedelic Studies · doi:10.1556/2054.2019.017 · Cited by 25
Psychedelics and Psychedelic-Assisted Psychotherapy
Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodríguez, C. I., Kalin, N. H., & McDonald, W. M. (2021) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.19104 · Cited by 28
Scaling Up: Multisite Open-Label Clinical Trials of MDMA-Assisted Therapy for Severe Posttraumatic Stress Disorder
Wang, J. B., Lin, J., Bedrosian, L., Coker, A. R., Jerome, I., Feduccia, A. A., Lilienstein, A., Harrison, C., Heimler, E., Mithoefer, M. C., et al. (2021) · Journal of Humanistic Psychology · doi:10.1177/00221678211023663 · Cited by 25
Hallucinogenic drugs and their potential for treating fear‐related disorders: Through the lens of fear extinction
Glavonic, E., Mitić, M., & Adžić, M. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25017 · Cited by 21
Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents
Jones, G. M., Arias, D., & Nock, M. K. (2022) · Scientific Reports · doi:10.1038/s41598-022-25658-5 · Cited by 23
Prospective associations of psychedelic treatment for co-occurring alcohol misuse and posttraumatic stress symptoms among United States Special Operations Forces Veterans
Armstrong, S. B., Xin, Y., Sepeda, N. D., Polanco, M., Averill, L. A., & Davis, A. K. (2023) · Military Psychology · doi:10.1080/08995605.2022.2156200 · Cited by 24
Greater empathy in MDMA users
Carlyle, M., Stevens, T., Fawaz, L., Marsh, B., Kosmider, S., & Morgan, C. J. A. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119826594 · Cited by 25
Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis
Højlund, M., Kafalı, H. Y., Kırmızı, B., Fusar‐Poli, P., Correll, C. U., Cortese, S., Sabé, M., Fiedorowicz, J. G., Saraf, G., Zein, J., et al. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2025.09.011 · Cited by 23
Use of cannabinoids for the treatment of patients with post-traumatic stress disorder
Forsythe, M. L., & Boileau, A. J. (2021) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2020-0279 · Cited by 20
MDMA treatment paired with a trauma-cue promotes adaptive stress responses in a translational model of PTSD in rats
Arluk, S., Matar, M. A., Carmi, L., Arbel, O., Zohar, J., Todder, D., & Cohen, H. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01952-8 · Cited by 23
Placebo Problems: Boundary Work in the Psychedelic Science Renaissance
Hendy, K. (2018) · Springer eBooks · doi:10.1007/978-3-319-76720-8_9 · Cited by 20
3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner
Pitts, E. G., Minerva, A. R., Chandler, E. B., Kohn, J. N., Logun, M. T., Sulima, A., Rice, K. C., & Howell, L. L. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.80 · Cited by 20
Key interindividual determinants in MDMA pharmacodynamics
Papaseit, E., Torrens, M., Pérez‐Mañá, C., Muga, R., & Farré, M. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1424832 · Cited by 20
Methylenedioxymethamphetamine is a connectogen with empathogenic, entactogenic, and still further connective properties: It is time to reconcile “the great entactogen-empathogen debate
Stocker, K., & Liechti, M. E. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241265352 · Cited by 19
The efficacy and safety of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review and meta-analysis from randomized controlled trials
Yang, J., Wang, N., Luo, W., & Gao, J. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116043 · Cited by 23
A Comparative Review of the Neuro-Psychopharmacology of Hallucinogen-Induced Altered States of Consciousness: The Uniqueness of Some Hallucinogens
Sayın, Ü. (2012) · NeuroQuantology · doi:10.14704/nq.2012.10.2.528 · Cited by 19
Overcoming epistemic injustices in the biomedical study of ayahuasca: Towards ethical and sustainable regulation
Schenberg, E. E., & Gerber, K. (2022) · Transcultural Psychiatry · doi:10.1177/13634615211062962 · Cited by 21
Enhancing Psychological Interventions for Post-Traumatic Stress Disorder (PTSD) Treatment with Memory Influencing Drugs
Marchetta, E., Mancini, G. F., Morena, M., & Campolongo, P. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21666221207162750 · Cited by 17
MDMA-assisted psychotherapy for PTSD: Growing evidence for memory effects mediating treatment efficacy
Sarmanlu, M., Kuypers, K. P. C., Vizeli, P., & Kvamme, T. L. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110843 · Cited by 21
Oxytocin, cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of recreational ‘ecstasy’
Parrott, A. C. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000262 · Cited by 21
Posttraumatic stress disorder: An integrated overview of the neurobiological rationale for pharmacology.
Kelmendi, B., Adams, T. G., Southwick, S. M., Abdallah, C. G., & Krystal, J. H. (2017) · Clinical Psychology Science and Practice · doi:10.1111/cpsp.12202 · Cited by 20
Psychedelics and Evidence-based Psychotherapy
Leone, L., McSpadden, B., DeMarco, A., Enten, L., Kline, R., & Fonzo, G. A. (2024) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2024.02.006 · Cited by 18
MDMA-assisted psychotherapy for post-traumatic stress disorder: The devil is in the detail
Bedi, G., Cotton, S. M., Guerin, A. A., & Jackson, H. J. (2022) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674221127186 · Cited by 18

Authors: Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R.
Affiliations: Private Practice of Psychiatry and Clinical Research, Mount Pleasant SC, USA.
Medical University of South Carolina (US)
Multidisciplinary Association for Psychedelic Studies (US)
Corresponding author: Mithoefer, Michael C
ORCID: Mithoefer, Michael C
Jerome, Lisa
Doblin, Rick
Venue: Journal of Psychopharmacology
Publisher: SAGE Publications
Published: 2010-07-19
Volume: 25
Issue: 4
Pages: 439-452
ISSN: 0269-8811 (ISSN-L)
1461-7285
DOI: 10.1177/0269881110378371
PMC: PMC3122379
OpenAlex: W2089149909
Cited by: 674
References: 67
Citations by year: 2026: 30 · 2025: 36 · 2024: 75 · 2023: 49 · 2022: 52 · 2021: 41 · 2020: 61 · 2019: 62 · 2018: 59 · 2017: 45 · 2016: 28 · 2015: 27 · 2014: 23 · 2013: 44 · 2012: 26
FWCI: 29.42
Type: journal article
Language: en
Update notices: correction (2011-06-01)
Open access: hybrid
doi.org
Licence: cc-by-nc
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Journal of Psychopharmacology (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Keywords: MDMA-assisted psychotherapy, MDMA, 3,4-methylenedioxymethamphetamine, post-traumatic stress disorder, treatment-resistant PTSD, chronic PTSD, psychedelic therapy, Clinician-Administered PTSD Scale, adverse events, neurocognitive effects, blood pressure
MeSH terms: Adult, Aged, Double-Blind Method, Fear, Female, Humans, Male, Middle Aged, Music Therapy, Pilot Projects, Placebos, Psychiatric Status Rating Scales, Psychotherapy, Stress Disorders, Post-Traumatic, Treatment Outcome, Serotonin Agents, Cross-Over Studies, N-Methyl-3,4-methylenedioxyamphetamine, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks